NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

Cytogenetics and European Leukemia Net (ELN) genetic classification predict patients at increased risk of relapse in acute myeloid leukemia (AML) except in the intermediate risk group for which further prognostic determinants are required. We have previously shown that Natural Killer (NK) cell defec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Chretien, Anne-Sophie, Fauriat, Cyril, Orlanducci, Florence, Rey, Jerome, Borg, Gaelle Bouvier, Gautherot, Emmanuel, Granjeaud, Samuel, Demerle, Clemence, Hamel, Jean-François, Cerwenka, Adelheid, von Strandmann, Elke Pogge, Ifrah, Norbert, Lacombe, Catherine, Cornillet-Lefebvre, Pascale, Delaunay, Jacques, Toubert, Antoine, Arnoulet, Christine, Vey, Norbert, Olive, Daniel
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2017
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564787/
https://ncbi.nlm.nih.gov/pubmed/28548938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17747
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge